|
1
|
Leung PC: Diabetic foot ulcers-a
comprehensive review. Surgeon. 5:219–231. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Unwin N: The diabetic foot in the
developing world. Diabetes Metab Res Rev. 24 Suppl 1:S31–S33. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu Y, Wang L, He J, Bi Y, Li M, Wang T,
Wang L, Jiang Y, Dai M, Lu J, et al: Prevalence and control of
diabetes in Chinese adults. JAMA. 310:948–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Izumi Y, Satterfield K, Lee S and Harkless
LB: Risk of reamputation in diabetic patients stratified by limb
and level of amputation: A 10-year observation. Diabetes Care.
29:566–570. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lepore G, Maglio ML, Cuni C, Dodesini AR,
Nosari I, Minetti B and Trevisan R: Poor glucose control in the
year before admission as a powerful predictor of amputation in
hospitalized patients with diabetic foot ulceration. Diabetes Care.
29:19852006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boulton AJ: The diabetic foot: A global
view. Diabetes Metab Res Rev. 16 Suppl 1:S2–S5. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zykova SN, Svartberg J, Seljelid R,
Iversen H, Lund A, Svistounov DN and Jenssen TG: Release of
TNF-alpha from in vitro-stimulated monocytes is negatively
associated with serum levels of apolipoprotein B in patients with
type 2 diabetes. Scand J Immunol. 60:535–542. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shau H, Gupta RK and Golub SH:
Identification of a natural killer enhancing factor (NKEF) from
human erythroid cells. Cell Immunol. 147:1–11. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thorsby P, Undlien DE, Berg JP, Thorsby E
and Birkeland KI: Diabetes mellitus-a complex interaction between
heredity and environment. Tidsskr Nor Laegeforen. 118:2519–2524.
1998.(In Norwegian). PubMed/NCBI
|
|
10
|
Bouter KP, Meyling FH, Hoekstra JB,
Masurel N, Erkelens DW and Diepersloot RJ: Influence of blood
glucose levels on peripheral lymphocytes in patients with diabetes
mellitus. Diabetes Res. 19:77–80. 1992.PubMed/NCBI
|
|
11
|
Morán I, Akerman I, van de Bunt M, Xie R,
Benazra M, Nammo T, Arnes L, Nakić N, García-Hurtado J,
Rodríguez-Seguí S, et al: Human β cell transcriptome analysis
uncovers lncRNAs that are tissue-specific, dynamically regulated,
and abnormally expressed in type 2 diabetes. Cell Metab.
16:435–448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ,
Lee HY, Yang L, Mueller M, Zhou XB, Dandolo L, et al: The H19/let-7
double-negative feedback loop contributes to glucose metabolism in
muscle cells. Nucleic Acids Res. 42:13799–13811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen
C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 regulates
neointima formation, vascular smooth muscle cell proliferation,
apoptosis, and atherosclerosis by enhancing p53 activity.
Circulation. 130:1452–1465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alvarez ML and DiStefano JK: Functional
characterization of the plasmacytoma variant translocation 1 gene
(PVT1) in diabetic nephropathy. PLoS One. 6:e186712011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang JZ, Chen M, Chen, Gao XC, Zhu S,
Huang H, Hu M, Zhu H and Yan GR: A peptide encoded by a putative
lncRNA HOXB-AS3 suppresses colon cancer growth. Mol Cell.
68:171–184 e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang CT, Chen L, Chen WL, Li N, Chen MJ,
Li X, Zheng X, Zhao YZ, Wu YX, Xian MA and Liu J: Hydrogen sulfide
primes diabetic wound to close through inhibition of NETosis. Mol
Cell Endocrinol. 480:74–82. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lipsky BA, Peters EJ, Berendt AR,
Senneville E, Bakker K, Embil JM, Lavery LA, Urbančič-Rovan V and
Jeffcoate WJ; International Working Group on Diabetic Foot, :
Specific guidelines for the treatment of diabetic foot infections
2011. Diabetes Metab Res Rev. 28 Suppl 1:S234–S235. 2012.
View Article : Google Scholar
|
|
19
|
Boulton AJ: The pathogenesis of diabetic
foot problems: An overview. Diabet Med. 46 Suppl 2:S12–S16. 1996.
View Article : Google Scholar
|
|
20
|
Navarro-González JF and Mora-Fernández C:
The role of inflammatory cytokines in diabetic nephropathy. J Am
Soc Nephrol. 19:433–442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moura J, Rodrigues J, Goncalves M, Amaral
C, Lima M and Carvalho E: Impaired T-cell differentiation in
diabetic foot ulceration. Cell Mol Immunol. 14:758–769. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tanaka S, Isoda F, Ishihara Y, Kimura M
and Yamakawa T: T lymphopaenia in relation to body mass index and
TNF-alpha in human obesity: Adequate weight reduction can be
corrective. Clin Endocrinol (Oxf). 54:347–354. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Keane WF and Lyle PA: Reduction of
Endpoints in NIDDM with the Angiotensin II Receptor Antagonist
Losartan study: Recent advances in management of type 2 diabetes
and nephropathy: Lessons from the RENAAL study. Am J Kidney Dis. 41
(3 Suppl 1):S22–S25. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan X, Han L, Fu P, Zeng H, Lv C, Chang
W, Runyon RS, Ishii M, Han L, Liu K, et al: Cinnamaldehyde
accelerates wound healing by promoting angiogenesis via
up-regulation of PI3K and MAPK signaling pathways. Lab Invest.
98:783–798. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kremer KN, Kumar A and Hedin KE:
Haplotype-independent costimulation of IL-10 secretion by
SDF-1/CXCL12 proceeds via AP-1 binding to the human IL-10 promoter.
J Immunol. 178:1581–1588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin E, Ren M, Liu W, Liang S, Hu Q, Gu Y
and Li S: Effect of boron on thymic cytokine expression, hormone
secretion, antioxidant functions, cell proliferation, and apoptosis
potential via the extracellular Signal-regulated kinases 1 and 2
signaling pathway. J Agric Food Chem. 65:11280–11291. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang XL and Sun Q: Photodynamic therapy
with 5-aminolevulinic acid suppresses IFN-γ-induced K17 expression
in HaCaT cells via MAPK pathway. Eur Rev Med Pharmacol Sci.
21:4694–4702. 2017.PubMed/NCBI
|
